ArticleFrontiers in pharmacology2018

Inhibiting β-Catenin by β-Carboline-Type MDM2 Inhibitor for Pancreatic Cancer Therapy.

Jiang-Jiang Qin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.